openPR Logo
Press release

Nasal Polyposis Drugs Market Growth Fueled by Tezspire Phase III Win & Depemokimab FDA Submission | Mylan N.V., GlaxoSmithKline PLC, Lupin, Sanofi S.A

07-17-2025 02:56 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research LLP

Nasal Polyposis Drugs

Nasal Polyposis Drugs

"The Global Nasal Polyposis Drugs Market reached USD 3.52 billion in 2023 and is expected to reach USD 5.44 billion by 2030, growing at a CAGR of 6.41% during the forecast period 2023-2030," according to DataM Intelligence.

The Nasal Polyposis Drugs Market is dominated by global pharmaceutical companies including Mylan N.V., Intersect ENT Inc., GlaxoSmithKline PLC, Lupin, Sanofi S.A., Sun Pharma, Anant Pharmaceuticals, OptiNose, Teva Pharma, and Merck & Co. Inc. These players focus on expanding biologic pipelines, securing regulatory approvals, and enhancing market access through innovative therapies like monoclonal antibodies and nasal delivery systems to address chronic rhinosinusitis with nasal polyps (CRSwNP).

Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/nasal-polyposis-drugs-market?jd

Nasal Polyposis Drugs Market M&A & Strategic Collaborations

1. AstraZeneca & Amgen Phase III WAYPOINT success drives Tezspire regulatory submission for CRSwNP in H1 2025.
2. GSK's Depemokimab FDA biologics application accepted for CRSwNP in March 2025.
3. NIH awards US$7 million to OHSU for a head-to-head CRSwNP biologics trial investigating personalized treatment.

As per our analysis, these developments underline a surge in late-stage biologic trials, multi-year dosing innovations, and personalized medicine initiatives advancing the nasal polyposis landscape.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nasal-polyposis-drugs-market?jd

Key Growth Drivers & Emerging Opportunities in the Nasal Polyposis Drugs Market

• Launch of first-in-class biologics (Tezspire, Depemokimab, Dupixent, Nucala) targeting TSLP, IL-5, IL 4/13 pathways.
• Regulatory momentum with CRSwNP indications being fast-tracked by the FDA and EMA.
• Reduced dosing frequency via ultra-long-acting biologics, increasing patient adherence.
• Insurance coverage improvements for biologic nasal therapies.
• Precision medicine initiatives like the OHSU-funded mucus profiling study enable patient-specific biologic strategies.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=nasal-polyposis-drugs-market?jd

Regional Market Drivers in the Nasal Polyposis Drugs Market

North America leads in regulatory approvals, high biologic uptake, and payer support.
Europe benefits from strong biologics adoption and multipolar approvals in CRSwNP.
Asia-Pacific is expanding fast due to rising CRSwNP prevalence, increasing healthcare infrastructure, and the launch of GSK biologics.
Latin America & MEA are early-stage markets, bolstered by chronic sinusitis awareness, biologic availability, and global health programs.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?jd
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nasal Polyposis Drugs Market Growth Fueled by Tezspire Phase III Win & Depemokimab FDA Submission | Mylan N.V., GlaxoSmithKline PLC, Lupin, Sanofi S.A here

News-ID: 4108535 • Views:

More Releases from DataM Intelligence 4Market Research LLP

NASH/MASH Treatment Market Opportunity in Obesity-Co-Morbidity Therapies and GLP 1 Combo Approaches
NASH/MASH Treatment Market Opportunity in Obesity-Co-Morbidity Therapies and GLP …
"The Global NASH/MASH Treatment Market reached US$7.87 billion in 2024 and is expected to reach US$31.76 billion by 2033, growing at a CAGR of 17.7% during the forecast period 2025-2033," according to DataM Intelligence. The approved drugs market value is reported at US$178.31 million in 2024 and is expected to reach US$16.82 billion in 2033, growing at a CAGR of 57.05%. As per our analysis, the NASH/MASH Treatment Market is
Pharmaceutical Visual Inspection Systems Market Growth Fueled by AI & Automation, Reaching USD 1.9 Billion by 2033
Pharmaceutical Visual Inspection Systems Market Growth Fueled by AI & Automation …
"The Pharmaceutical Visual Inspection Systems Market size reached US$966.13 Million in 2024 and is expected to reach US$1,898.23 Million by 2033, growing at a CAGR of 7.9% during the forecast period 2025-2033," according to DataM Intelligence. The Pharmaceutical Visual Inspection Systems Market comprises prominent global manufacturers including DAIICHI JITSUGYO VISWILL, Stevanato Group, Syntegon Technology, Sensum d.o.o., Yenchen Machinery, United Pharmatek USA, Key International, Meliscout GmbH, Brevetti Cea, and SaintyCo. Together, they
Medical Case Management Market Innovation Accelerates with AI, Telemedicine, Cloud-Based Platforms, and Predictive Analytics
Medical Case Management Market Innovation Accelerates with AI, Telemedicine, Clo …
"The Medical Case Management Market reached US$5.28 billion in 2024 and is expected to reach US$9.26 billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033," according to DataM Intelligence. Key global players include Genex Services, EagleOne Case Management Solutions, EK Health Services, Healthcare Solutions Inc., Europ Assistance - Global Corporate Solutions, Precyse Solutions, Axiom Medical Consulting, Managed Medical Review Organization, Medical Case Management Group, CareCloud
Distance Health Technology Market Growth Driven by Telemedicine, Remote Patient Monitoring & AI Analytics | Omcare, Teladoc Health, Inc., Tryten Technologies, Inc.
Distance Health Technology Market Growth Driven by Telemedicine, Remote Patient …
"The Global Distance Health Technology Market is projected to be valued at USD 40.00 billion in 2025 and is expected to reach USD 179.5 billion by 2035, growing at a CAGR of 16.2% during the forecast period 2025-2035," according to DataM Intelligence. The leading companies with a significant market share include Omcare, Teladoc Health, Inc., Tryten Technologies, Inc., Rudolf Riester GmbH, Visionflex Pty Limited, Advantech Co., Ltd., Dreamsoft4u, Koninklijke Philips N.V.,

All 5 Releases


More Releases for Drug

Drug Device Combination Market 2024: Enhanced Drug Delivery Solutions Fuel Growt …
The Drug-Device Combination Market sector is undergoing significant transformation, with substantial growth and technological advancements expected by 2031. According to a new in-depth market research report, the sector is poised for expansion, driven by various factors such as market size, share, and emerging trends. This comprehensive report provides key insights into the Drug-Device Combination market, exploring critical market segmentation and definitions. It highlights the essential components driving growth, offering a clear
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Drug Repurposing Market - Empowering drug discovery through effective repurposin …
Newark, New Castle, USA: The "Drug Repurposing Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Drug Repurposing Market: https://www.growthplusreports.com/report/drug-repurposing-market/8609 This latest report researches the industry structure, sales, revenue,
Drug Discovery Outsourcing Impact and Global Market Analysis By Drug Type
As the process of new drug discovery is getting more expensive and time consuming most of the pharmaceutical and biotech market players are focusing on outsourcing solutions. Generally, drug discovery outsourcing solution comprised of development and testing of pipeline drug molecules. Download PDF @ https://www.theinsightpartners.com/sample/TIPRE00016852/?utm_source=OpenPR&utm_medium=10379 Pharmaceutical companies are increasingly outsourcing research activities to academic and private contract research organizations (CROs) in order to stay competitive in market. Market for drug discovery